| Charles River to Buy China Firm Charles River is expected to announce the acquisition of one of China's largest drug research contractors, WuXi AppTec, for $1.6 billion. online.wsj.com |
eyeforpharma: Sales Force Effectiveness - Video Several Key Themes About Change and Customer-Centricity Emerged at This Year’s eyeforpharma’s SFE 2010 Conference in Barcelona, April 27-29th. feedproxy.google.com |
Hedge Fund MHR Receives More Convertible Notes From Emisphere Technologies Market Folly submits:MHR Fund Management run by Mark Rachesky recently filed a Form 4 with the SEC in regards to Emisphere Technologies (EMIS). Per the filing, Rachesky's firm received convertible notes on EMIS for reasons we'll discuss below. We see that MHR acquired $1,272,753 worth of convertibles with an exercise price of $3.78 and an exercise date of September 26th, 2012. These convertibles in aggregate represent 336,705 shares of common stock in Emisphere Technologies.This is not the first time MHR has acquired EMIS convertibles either. Rachesky's firm has owned 11% Senior Secured Convertible Notes since May 16th, 2006. These convertibles have interestComplete Story » seekingalpha.com |
Coverage After Cobra A growing number of the unemployed are exhausting their extended Cobra health-insurance subsidies. There's a slim chance that Congress could extend the subsidy again this fall, but most experts think it's unlikely. online.wsj.com |
Blood-Thinning Drug Gets Nod An FDA panel recommended that the FDA approve Boehringer's blood-thinning drug Pradaxa, a move likely to place the company as the first to get a new type of drug on the U.S. market to prevent strokes in patients with irregular heart rhythms. online.wsj.com |